PHARMACY

APhA calls for award submissions

BY Brian Berk

WASHINGTON — The American Pharmacists Association Foundation is seeking nominations for its 2017 Pinnacle Awards. Established in 1998, the Pinnacle Awards honor significant contributions to health care quality via the medication use process.

There are the three award categories in which nominations can be made:

  • Individual Award for career achievement
  • Group practices, health systems, health care corporations
  • Voluntary health agencies, nonprofit organizations, associations, government agencies, and public/private partnerships.

Nominations are due by Sunday June 18 at 11:59 p.m. PDT. Winners will be recognized at the 2017 Pinnacle Awards ceremony at APhA headquarters on Sept. 18.

For more information about the awards, click here.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?
PHARMACY

Lawmakers revise generic drug legislation

BY Brian Berk

WASHINGTON — Legislation intended to require the U.S. Food and Drug Administration to act upon applications for generic drugs within 180 days of being filed that are in short supply or when there are too few manufacturers on the market is being revised, a House Energy and Commerce Committee aide told Bloomberg.

H.R. 749 was introduced Jan. 30 by Reps. Gus Bilirakis (R- Fla.) and Kurt Schrader (D-Ore.). It is intended to lower drug prices by having more generic competition. The bill also would create a transferable priority review voucher that the FDA would award to a manufacturer that brings a generic drug to market when a branded product doesn’t have any competition.

 “There are a group of drugs where there’s not a lot of competition where this could help expedite the review process if FDA would be able to meet that 180-day time clock,” David Rosen, an attorney with Foley & Lardner LLP in Washington, told Bloomberg. “Rosen is the chair of the firm’s FDA regulatory practice and was employed at the FDA for 14 years.

However, it is unclear if a 180-day window to approve generic drugs is doable. “The net benefits and practical feasibility of a six-month review are unclear as is, consequently, the market value of a priority review voucher for generic applications,” said Allan Coukell, senior director for health programs at the Pew Charitable Trusts. “Perhaps more important than shortening the duration of review is reducing the number of review cycles.”

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?
PHARMACY

Albertsons expands Eating Healthy With Diabetes store tours

BY David Salazar
BOISE, Idaho — Albertsons’ Eating Healthy With Diabetes store tours — which make available to patients a guided tour with a registered dietitian to help make better food choices, set goals and read nutrition labels — are getting an expansion, the company announced Thursday. 
 
Through April 30, there will be free, guided tours at 400 of the company’s stores with in-store pharmacies under the Albertsons, Safeway, Vons, Jewel-Osco, Shaw's, ACME, Tom Thumb, Randalls, Pavilions, Star Market and Carrs banners.
 
“We hope that all of our customers who are interested in taking charge of their health and wellness goals can attend the free tours,” said Mark Panzer, SVP, Pharmacy Health and Wellness. “This is one more way our stores can be a solution center for our patients and customers.”
 
The tours, which were developed more than 10 years ago when Albertsons pharmacists realized their patients with diabetes needed more resources in addition to their medications, have been updated to include food tastings, meal planning tips and nutrition tools. The company welcomes all patients to participate, regardless of diabetes status. The tours are sponsored by LifeScan, which makes OneTouch products. 
 
keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?